Cigna
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Volatility surge has trader eyeing one 'stable' stock
With semis whipping around on every AI headline and index volatility spiking, I'm looking for a counterpoint, a stable, cash-generating business where I can sell volatility instead of buying drama. Cigna (CI) fits the bill — and I'd rather write my way into the stock than chase it. Cigna isn't a growth story.
Providers, not insurers, are responsible for excess U.S. health care cost (2024)
Insurers aren't the main villain of the U.S. health care system A repost from the Noahpinion archive. In a post last week, I wrote about the progressive anti-monopoly movement’s increasing disconnect from reality. [C]onsider the movement’s choice of targets.
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs. Novo Nordisk on Sunday announced that prescriptions of the Wegovy pill have topped 3 million since it entered the U.S. market about five months ago. The Danish drugmaker's CEO Mike Doustdar celebrated the milestone, saying in an interview with CNBC that Novo was able to accelerate prescriptions even as Lilly...